+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Prostate Fusion Biopsy Market - Global Forecast 2026-2032- Product Image
Prostate Fusion Biopsy Market - Global Forecast 2026-2032- Product Image
Sale

Prostate Fusion Biopsy Market - Global Forecast 2026-2032

  • Report

  • 183 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6150262
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Prostate Fusion Biopsy Market is projected to reach USD 2.19 Billion in 2026. It is expected to continue growing at a CAGR of 8.64%, reaching USD 3.60 Billion by 2032.

Prostate Fusion Biopsy: Executive Overview

Prostate fusion biopsy combines multiparametric magnetic resonance imaging with real-time ultrasound to target suspicious prostate lesions more precisely than systematic sampling alone. Its clinical value is linked to improved lesion targeting, risk stratification, and support for treatment planning, while adoption depends on imaging quality, biopsy expertise, equipment access, reimbursement, and care pathways.

Clinical Workflow Is Shifting Toward Image-Guided Diagnosis

The field is moving from predominantly systematic biopsy toward MRI-informed targeted sampling, often alongside systematic cores when clinically appropriate. This shift places greater emphasis on standardized MRI acquisition and interpretation, lesion scoring, image-registration accuracy, transperineal techniques, infection prevention, pathology coordination, and multidisciplinary decision-making. Providers must also manage patient selection, repeat-biopsy pathways, and communication of uncertain findings.

Artificial Intelligence Strengthens Detection, Triage, and Quality Control

Artificial intelligence is increasingly applied to prostate MRI through lesion detection, segmentation, image-quality assessment, risk prioritization, and workflow support. Its cumulative impact is greatest when algorithms augment radiologists and urologists rather than replace clinical judgment. Effective deployment requires representative validation data, transparent performance monitoring, interoperability with imaging and biopsy systems, cybersecurity safeguards, and clear accountability for false-positive and false-negative results.

Regional Insights: Uneven Access Shapes Adoption

North America benefits from established urology, radiology, and advanced imaging infrastructure, although reimbursement and variation in local expertise influence uptake. Europe is supported by structured diagnostic pathways and broad clinical interest in MRI-led evaluation, with implementation differing across health systems. Asia-Pacific combines advanced centers with substantial access gaps between metropolitan and rural settings. Latin America is shaped by uneven availability of MRI, trained specialists, and pathology services. The Middle East shows concentrated investment in tertiary care, while Africa faces stronger constraints in imaging capacity, specialist availability, and follow-up continuity.

Group Insights: Policy Alignment and Infrastructure Determine Readiness

ASEAN markets reflect diverse levels of imaging access, training, and health-system integration. BRICS countries combine large and varied patient populations with significant differences in diagnostic infrastructure and regional affordability. The European Union emphasizes coordinated clinical standards while retaining national differences in reimbursement and service organization. G7 systems generally have mature specialist networks but continue to address capacity, access, and value-based care considerations. GCC countries benefit from concentrated healthcare investment and tertiary facilities, whereas NATO members span highly developed systems and markets where access remains uneven. Across all groups, workforce capability and standardized protocols are central adoption conditions.

Country Insights: Capacity and Clinical Practice Vary Widely

The United States and Canada have developed specialist capabilities, with access influenced by insurance coverage, regional resources, and referral pathways. The United Kingdom, France, Germany, Italy, and Spain are shaped by national or regional diagnostic protocols, MRI availability, and workforce capacity. Australia combines advanced tertiary services with geographic access challenges. Japan and South Korea have sophisticated medical infrastructure, while China and India show substantial variation between major urban centers and less-resourced areas. Brazil, Mexico, and Russia face regional differences in equipment, specialist availability, and continuity of care. Across these countries, adoption is strengthened by validated protocols, training, and integration between radiology, urology, and pathology.

Priorities for Leaders: Build Reliable, Integrated Diagnostic Pathways

Industry leaders should standardize MRI acquisition, reporting, lesion targeting, and pathology workflows before scaling services. Investment should prioritize workforce training, image-registration quality, transperineal capability where appropriate, infection-control processes, and interoperability across clinical systems. Organizations should evaluate outcomes using clinically meaningful measures such as detection of clinically significant disease, avoidable procedures, complications, turnaround time, and patient experience. AI programs should begin with prospective validation, subgroup performance checks, human oversight, and post-deployment monitoring. Partnerships with payers and health authorities can support equitable access, while referral networks can extend specialist expertise beyond major centers.

Research Methodology: Evidence-Based Synthesis of Clinical and System Factors

This executive summary uses the supplied market scope-prostate fusion biopsy-and synthesizes established clinical, technological, and health-system considerations from the defined regional, group, and country coverage. The assessment emphasizes peer-reviewed evidence, clinical guidance, regulatory principles, and documented care-delivery patterns. It excludes market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims. Regional and geographic observations are framed qualitatively to distinguish infrastructure, workforce, policy, and access conditions without implying uniformity within any geography.

Conclusion: Adoption Depends on Accuracy, Integration, and Equitable Access

Prostate fusion biopsy is becoming an important component of MRI-informed prostate cancer diagnosis, but its value depends on the reliability of the entire pathway rather than on equipment alone. Consistent imaging, skilled interpretation, precise targeting, high-quality pathology, and coordinated clinical decisions are essential. Leaders that combine disciplined implementation with responsible AI evaluation, workforce development, and access-focused planning will be better positioned to improve diagnostic confidence while limiting unnecessary procedures and regional disparities.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Prostate Fusion Biopsy Market, by Technology
7.1. Introduction
7.2. Cognitive Fusion
7.3. Robotic Fusion
7.3.1. Fully Automated Systems
7.3.2. Semi-Automated Systems
7.4. Software Fusion
7.4.1. Intraoperative Navigation
7.4.2. Postoperative Analysis
7.4.3. Preoperative Planning
8. Prostate Fusion Biopsy Market, by Route
8.1. Introduction
8.2. Transperineal
8.2.1. Freehand Transperineal
8.2.2. Template-Guided Transperineal
8.3. Transrectal
8.3.1. Freehand Transrectal
8.3.2. Stepper Mounted Transrectal
9. Prostate Fusion Biopsy Market, by Component
9.1. Introduction
9.2. Consumables
9.2.1. Contrast Agents
9.2.2. Sterile Drapes
9.3. Hardware
9.4. Software
9.4.1. Fusion Software
9.4.1.1. Image Registration
9.4.1.2. Real-Time Tracking
9.4.2. Navigation Software
10. Prostate Fusion Biopsy Market, by Modality
10.1. Introduction
10.2. MRI-US Fusion
10.2.1. Ex-Bore MRI Fusion
10.2.2. In-Bore MRI Fusion
10.3. PET-US Fusion
10.3.1. PET-CT Fusion
10.3.2. PET-MRI Fusion
11. Prostate Fusion Biopsy Market, by End User
11.1. Introduction
11.2. Ambulatory Surgery Centers
11.2.1. Multispecialty Centers
11.2.2. Single-Specialty Centers
11.3. Hospitals
11.3.1. Academic Medical Centers
11.3.2. Community Hospitals
11.4. Specialty Clinics
11.4.1. Oncology Clinics
11.4.2. Urology Clinics
12. Prostate Fusion Biopsy Market, by Application
12.1. Introduction
12.2. Diagnostic
12.2.1. Primary Diagnosis
12.2.2. Recurrence Evaluation
12.3. Therapeutic
12.3.1. Cryoablation Guidance
12.3.2. Targeted Drug Delivery
13. Prostate Fusion Biopsy Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Prostate Fusion Biopsy Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Prostate Fusion Biopsy Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. BioJet Systems GmbH
17.2. BioTrace Medical, LLC
17.3. BK Medical Holding Company, Inc.
17.4. Canon Medical Systems Corporation
17.5. CIVCO Medical Solutions, Inc.
17.6. Esaote S.p.A.
17.7. FUJIFILM Holdings Corporation
17.8. GE HealthCare Technologies Inc.
17.9. Hitachi, Ltd.
17.10. KOELIS SA
17.11. Koninklijke Philips N.V.
17.12. Medtronic plc
17.13. Siemens Healthineers AG
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Prostate Fusion Biopsy Market, Years Considered for the Study
FIGURE 2. Global Prostate Fusion Biopsy Market, Research Design
FIGURE 3. Global Prostate Fusion Biopsy Market, Research Framework
FIGURE 4. Global Prostate Fusion Biopsy Market, Data Triangulation
FIGURE 5. Global Prostate Fusion Biopsy Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Prostate Fusion Biopsy Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Prostate Fusion Biopsy Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Prostate Fusion Biopsy Market Size, by Route, 2025 vs 2032 (%)
FIGURE 9. Global Prostate Fusion Biopsy Market Size, by Route, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Prostate Fusion Biopsy Market Size, by Component, 2025 vs 2032 (%)
FIGURE 11. Global Prostate Fusion Biopsy Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Prostate Fusion Biopsy Market Size, by Modality, 2025 vs 2032 (%)
FIGURE 13. Global Prostate Fusion Biopsy Market Size, by Modality, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Prostate Fusion Biopsy Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Prostate Fusion Biopsy Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Prostate Fusion Biopsy Market Size, by Application, 2025 vs 2032 (%)
FIGURE 17. Global Prostate Fusion Biopsy Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Prostate Fusion Biopsy Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Prostate Fusion Biopsy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Prostate Fusion Biopsy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Prostate Fusion Biopsy Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Prostate Fusion Biopsy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Prostate Fusion Biopsy Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Prostate Fusion Biopsy Market Segmentation & Coverage
TABLE 2. Global Prostate Fusion Biopsy Market Size, 2017-2032 (USD Million)
TABLE 3. Global Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Cognitive Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Cognitive Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Cognitive Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Robotic Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Robotic Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Robotic Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Fully Automated Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Fully Automated Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Fully Automated Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Semi-Automated Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Semi-Automated Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Semi-Automated Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Software Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Software Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Software Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Intraoperative Navigation Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Intraoperative Navigation Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Intraoperative Navigation Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Postoperative Analysis Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Postoperative Analysis Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Postoperative Analysis Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Preoperative Planning Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Preoperative Planning Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Preoperative Planning Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Prostate Fusion Biopsy Market Size, by Route, 2017-2032 (USD Million)
TABLE 29. Global Transperineal Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Transperineal Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Transperineal Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Freehand Transperineal Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Freehand Transperineal Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Freehand Transperineal Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Template-Guided Transperineal Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Template-Guided Transperineal Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Template-Guided Transperineal Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Transrectal Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Transrectal Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Transrectal Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Freehand Transrectal Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Freehand Transrectal Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Freehand Transrectal Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Stepper Mounted Transrectal Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Stepper Mounted Transrectal Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Stepper Mounted Transrectal Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Prostate Fusion Biopsy Market Size, by Component, 2017-2032 (USD Million)
TABLE 48. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Contrast Agents Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Contrast Agents Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Contrast Agents Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Sterile Drapes Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Sterile Drapes Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Sterile Drapes Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Hardware Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Hardware Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Hardware Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Fusion Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Fusion Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Fusion Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Image Registration Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Image Registration Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Image Registration Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Real-Time Tracking Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Real-Time Tracking Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Real-Time Tracking Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Navigation Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Navigation Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Navigation Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Prostate Fusion Biopsy Market Size, by Modality, 2017-2032 (USD Million)
TABLE 76. Global MRI-US Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Global MRI-US Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 78. Global MRI-US Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 79. Global Ex-Bore MRI Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Ex-Bore MRI Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Ex-Bore MRI Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global In-Bore MRI Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global In-Bore MRI Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global In-Bore MRI Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global PET-US Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global PET-US Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global PET-US Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global PET-CT Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global PET-CT Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global PET-CT Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global PET-MRI Fusion Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global PET-MRI Fusion Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global PET-MRI Fusion Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Prostate Fusion Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 95. Global Ambulatory Surgery Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Ambulatory Surgery Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Ambulatory Surgery Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Multispecialty Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Multispecialty Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Multispecialty Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Single-Specialty Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Single-Specialty Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Single-Specialty Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Academic Medical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Academic Medical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Academic Medical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Community Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Community Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Community Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Oncology Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Oncology Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Oncology Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Urology Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Urology Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Urology Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Prostate Fusion Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 123. Global Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Primary Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Primary Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Primary Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Recurrence Evaluation Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Recurrence Evaluation Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Recurrence Evaluation Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Therapeutic Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Therapeutic Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Therapeutic Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Cryoablation Guidance Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Cryoablation Guidance Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Cryoablation Guidance Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Targeted Drug Delivery Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Targeted Drug Delivery Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Targeted Drug Delivery Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Prostate Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Asia-Pacific Prostate Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Asia-Pacific Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 144. Asia-Pacific Prostate Fusion Biopsy Market Size, by Robotic Fusion, 2017-2032 (USD Million)
TABLE 145. Asia-Pacific Prostate Fusion Biopsy Market Size, by Software Fusion, 2017-2032 (USD Million)
TABLE 146. Asia-Pacific Prostate Fusion Biopsy Market Size, by Route, 2017-2032 (USD Million)
TABLE 147. Asia-Pacific Prostate Fusion Biopsy Market Size, by Transperineal, 2017-2032 (USD Million)
TABLE 148. Asia-Pacific Prostate Fusion Biopsy Market Size, by Transrectal, 2017-2032 (USD Million)
TABLE 149. Asia-Pacific Prostate Fusion Biopsy Market Size, by Component, 2017-2032 (USD Million)
TABLE 150. Asia-Pacific Prostate Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 151. Asia-Pacific Prostate Fusion Biopsy Market Size, by Software, 2017-2032 (USD Million)
TABLE 152. Asia-Pacific Prostate Fusion Biopsy Market Size, by Fusion Software, 2017-2032 (USD Million)
TABLE 153. Asia-Pacific Prostate Fusion Biopsy Market Size, by Modality, 2017-2032 (USD Million)
TABLE 154. Asia-Pacific Prostate Fusion Biopsy Market Size, by MRI-US Fusion, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Prostate Fusion Biopsy Market Size, by PET-US Fusion, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Prostate Fusion Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Prostate Fusion Biopsy Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Prostate Fusion Biopsy Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Prostate Fusion Biopsy Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Prostate Fusion Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Prostate Fusion Biopsy Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Prostate Fusion Biopsy Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 163. North America Prostate Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. North America Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. North America Prostate Fusion Biopsy Market Size, by Robotic Fusion, 2017-2032 (USD Million)
TABLE 166. North America Prostate Fusion Biopsy Market Size, by Software Fusion, 2017-2032 (USD Million)
TABLE 167. North America Prostate Fusion Biopsy Market Size, by Route, 2017-2032 (USD Million)
TABLE 168. North America Prostate Fusion Biopsy Market Size, by Transperineal, 2017-2032 (USD Million)
TABLE 169. North America Prostate Fusion Biopsy Market Size, by Transrectal, 2017-2032 (USD Million)
TABLE 170. North America Prostate Fusion Biopsy Market Size, by Component, 2017-2032 (USD Million)
TABLE 171. North America Prostate Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 172. North America Prostate Fusion Biopsy Market Size, by Software, 2017-2032 (USD Million)
TABLE 173. North America Prostate Fusion Biopsy Market Size, by Fusion Software, 2017-2032 (USD Million)
TABLE 174. North America Prostate Fusion Biopsy Market Size, by Modality, 2017-2032 (USD Million)
TABLE 175. North America Prostate Fusion Biopsy Market Size, by MRI-US Fusion, 2017-2032 (USD Million)
TABLE 176. North America Prostate Fusion Biopsy Market Size, by PET-US Fusion, 2017-2032 (USD Million)
TABLE 177. North America Prostate Fusion Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. North America Prostate Fusion Biopsy Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 179. North America Prostate Fusion Biopsy Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 180. North America Prostate Fusion Biopsy Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 181. North America Prostate Fusion Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. North America Prostate Fusion Biopsy Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 183. North America Prostate Fusion Biopsy Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 184. Latin America Prostate Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 185. Latin America Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 186. Latin America Prostate Fusion Biopsy Market Size, by Robotic Fusion, 2017-2032 (USD Million)
TABLE 187. Latin America Prostate Fusion Biopsy Market Size, by Software Fusion, 2017-2032 (USD Million)
TABLE 188. Latin America Prostate Fusion Biopsy Market Size, by Route, 2017-2032 (USD Million)
TABLE 189. Latin America Prostate Fusion Biopsy Market Size, by Transperineal, 2017-2032 (USD Million)
TABLE 190. Latin America Prostate Fusion Biopsy Market Size, by Transrectal, 2017-2032 (USD Million)
TABLE 191. Latin America Prostate Fusion Biopsy Market Size, by Component, 2017-2032 (USD Million)
TABLE 192. Latin America Prostate Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 193. Latin America Prostate Fusion Biopsy Market Size, by Software, 2017-2032 (USD Million)
TABLE 194. Latin America Prostate Fusion Biopsy Market Size, by Fusion Software, 2017-2032 (USD Million)
TABLE 195. Latin America Prostate Fusion Biopsy Market Size, by Modality, 2017-2032 (USD Million)
TABLE 196. Latin America Prostate Fusion Biopsy Market Size, by MRI-US Fusion, 2017-2032 (USD Million)
TABLE 197. Latin America Prostate Fusion Biopsy Market Size, by PET-US Fusion, 2017-2032 (USD Million)
TABLE 198. Latin America Prostate Fusion Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 199. Latin America Prostate Fusion Biopsy Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 200. Latin America Prostate Fusion Biopsy Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 201. Latin America Prostate Fusion Biopsy Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 202. Latin America Prostate Fusion Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 203. Latin America Prostate Fusion Biopsy Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 204. Latin America Prostate Fusion Biopsy Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 205. Europe Prostate Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 206. Europe Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 207. Europe Prostate Fusion Biopsy Market Size, by Robotic Fusion, 2017-2032 (USD Million)
TABLE 208. Europe Prostate Fusion Biopsy Market Size, by Software Fusion, 2017-2032 (USD Million)
TABLE 209. Europe Prostate Fusion Biopsy Market Size, by Route, 2017-2032 (USD Million)
TABLE 210. Europe Prostate Fusion Biopsy Market Size, by Transperineal, 2017-2032 (USD Million)
TABLE 211. Europe Prostate Fusion Biopsy Market Size, by Transrectal, 2017-2032 (USD Million)
TABLE 212. Europe Prostate Fusion Biopsy Market Size, by Component, 2017-2032 (USD Million)
TABLE 213. Europe Prostate Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 214. Europe Prostate Fusion Biopsy Market Size, by Software, 2017-2032 (USD Million)
TABLE 215. Europe Prostate Fusion Biopsy Market Size, by Fusion Software, 2017-2032 (USD Million)
TABLE 216. Europe Prostate Fusion Biopsy Market Size, by Modality, 2017-2032 (USD Million)
TABLE 217. Europe Prostate Fusion Biopsy Market Size, by MRI-US Fusion, 2017-2032 (USD Million)
TABLE 218. Europe Prostate Fusion Biopsy Market Size, by PET-US Fusion, 2017-2032 (USD Million)
TABLE 219. Europe Prostate Fusion Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 220. Europe Prostate Fusion Biopsy Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 221. Europe Prostate Fusion Biopsy Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 222. Europe Prostate Fusion Biopsy Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 223. Europe Prostate Fusion Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 224. Europe Prostate Fusion Biopsy Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 225. Europe Prostate Fusion Biopsy Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 226. Middle East Prostate Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 227. Middle East Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 228. Middle East Prostate Fusion Biopsy Market Size, by Robotic Fusion, 2017-2032 (USD Million)
TABLE 229. Middle East Prostate Fusion Biopsy Market Size, by Software Fusion, 2017-2032 (USD Million)
TABLE 230. Middle East Prostate Fusion Biopsy Market Size, by Route, 2017-2032 (USD Million)
TABLE 231. Middle East Prostate Fusion Biopsy Market Size, by Transperineal, 2017-2032 (USD Million)
TABLE 232. Middle East Prostate Fusion Biopsy Market Size, by Transrectal, 2017-2032 (USD Million)
TABLE 233. Middle East Prostate Fusion Biopsy Market Size, by Component, 2017-2032 (USD Million)
TABLE 234. Middle East Prostate Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 235. Middle East Prostate Fusion Biopsy Market Size, by Software, 2017-2032 (USD Million)
TABLE 236. Middle East Prostate Fusion Biopsy Market Size, by Fusion Software, 2017-2032 (USD Million)
TABLE 237. Middle East Prostate Fusion Biopsy Market Size, by Modality, 2017-2032 (USD Million)
TABLE 238. Middle East Prostate Fusion Biopsy Market Size, by MRI-US Fusion, 2017-2032 (USD Million)
TABLE 239. Middle East Prostate Fusion Biopsy Market Size, by PET-US Fusion, 2017-2032 (USD Million)
TABLE 240. Middle East Prostate Fusion Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 241. Middle East Prostate Fusion Biopsy Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 242. Middle East Prostate Fusion Biopsy Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 243. Middle East Prostate Fusion Biopsy Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 244. Middle East Prostate Fusion Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. Middle East Prostate Fusion Biopsy Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 246. Middle East Prostate Fusion Biopsy Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 247. Africa Prostate Fusion Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 248. Africa Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 249. Africa Prostate Fusion Biopsy Market Size, by Robotic Fusion, 2017-2032 (USD Million)
TABLE 250. Africa Prostate Fusion Biopsy Market Size, by Software Fusion, 2017-2032 (USD Million)
TABLE 251. Africa Prostate Fusion Biopsy Market Size, by Route, 2017-2032 (USD Million)
TABLE 252. Africa Prostate Fusion Biopsy Market Size, by Transperineal, 2017-2032 (USD Million)
TABLE 253. Africa Prostate Fusion Biopsy Market Size, by Transrectal, 2017-2032 (USD Million)
TABLE 254. Africa Prostate Fusion Biopsy Market Size, by Component, 2017-2032 (USD Million)
TABLE 255. Africa Prostate Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 256. Africa Prostate Fusion Biopsy Market Size, by Software, 2017-2032 (USD Million)
TABLE 257. Africa Prostate Fusion Biopsy Market Size, by Fusion Software, 2017-2032 (USD Million)
TABLE 258. Africa Prostate Fusion Biopsy Market Size, by Modality, 2017-2032 (USD Million)
TABLE 259. Africa Prostate Fusion Biopsy Market Size, by MRI-US Fusion, 2017-2032 (USD Million)
TABLE 260. Africa Prostate Fusion Biopsy Market Size, by PET-US Fusion, 2017-2032 (USD Million)
TABLE 261. Africa Prostate Fusion Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Africa Prostate Fusion Biopsy Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 263. Africa Prostate Fusion Biopsy Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 264. Africa Prostate Fusion Biopsy Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 265. Africa Prostate Fusion Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 266. Africa Prostate Fusion Biopsy Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 267. Africa Prostate Fusion Biopsy Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 268. Global Prostate Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 269. ASEAN Prostate Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 270. ASEAN Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 271. ASEAN Prostate Fusion Biopsy Market Size, by Robotic Fusion, 2017-2032 (USD Million)
TABLE 272. ASEAN Prostate Fusion Biopsy Market Size, by Software Fusion, 2017-2032 (USD Million)
TABLE 273. ASEAN Prostate Fusion Biopsy Market Size, by Route, 2017-2032 (USD Million)
TABLE 274. ASEAN Prostate Fusion Biopsy Market Size, by Transperineal, 2017-2032 (USD Million)
TABLE 275. ASEAN Prostate Fusion Biopsy Market Size, by Transrectal, 2017-2032 (USD Million)
TABLE 276. ASEAN Prostate Fusion Biopsy Market Size, by Component, 2017-2032 (USD Million)
TABLE 277. ASEAN Prostate Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 278. ASEAN Prostate Fusion Biopsy Market Size, by Software, 2017-2032 (USD Million)
TABLE 279. ASEAN Prostate Fusion Biopsy Market Size, by Fusion Software, 2017-2032 (USD Million)
TABLE 280. ASEAN Prostate Fusion Biopsy Market Size, by Modality, 2017-2032 (USD Million)
TABLE 281. ASEAN Prostate Fusion Biopsy Market Size, by MRI-US Fusion, 2017-2032 (USD Million)
TABLE 282. ASEAN Prostate Fusion Biopsy Market Size, by PET-US Fusion, 2017-2032 (USD Million)
TABLE 283. ASEAN Prostate Fusion Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 284. ASEAN Prostate Fusion Biopsy Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 285. ASEAN Prostate Fusion Biopsy Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 286. ASEAN Prostate Fusion Biopsy Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 287. ASEAN Prostate Fusion Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 288. ASEAN Prostate Fusion Biopsy Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 289. ASEAN Prostate Fusion Biopsy Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 290. GCC Prostate Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 291. GCC Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 292. GCC Prostate Fusion Biopsy Market Size, by Robotic Fusion, 2017-2032 (USD Million)
TABLE 293. GCC Prostate Fusion Biopsy Market Size, by Software Fusion, 2017-2032 (USD Million)
TABLE 294. GCC Prostate Fusion Biopsy Market Size, by Route, 2017-2032 (USD Million)
TABLE 295. GCC Prostate Fusion Biopsy Market Size, by Transperineal, 2017-2032 (USD Million)
TABLE 296. GCC Prostate Fusion Biopsy Market Size, by Transrectal, 2017-2032 (USD Million)
TABLE 297. GCC Prostate Fusion Biopsy Market Size, by Component, 2017-2032 (USD Million)
TABLE 298. GCC Prostate Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 299. GCC Prostate Fusion Biopsy Market Size, by Software, 2017-2032 (USD Million)
TABLE 300. GCC Prostate Fusion Biopsy Market Size, by Fusion Software, 2017-2032 (USD Million)
TABLE 301. GCC Prostate Fusion Biopsy Market Size, by Modality, 2017-2032 (USD Million)
TABLE 302. GCC Prostate Fusion Biopsy Market Size, by MRI-US Fusion, 2017-2032 (USD Million)
TABLE 303. GCC Prostate Fusion Biopsy Market Size, by PET-US Fusion, 2017-2032 (USD Million)
TABLE 304. GCC Prostate Fusion Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 305. GCC Prostate Fusion Biopsy Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 306. GCC Prostate Fusion Biopsy Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 307. GCC Prostate Fusion Biopsy Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 308. GCC Prostate Fusion Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 309. GCC Prostate Fusion Biopsy Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 310. GCC Prostate Fusion Biopsy Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 311. European Union Prostate Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 312. European Union Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 313. European Union Prostate Fusion Biopsy Market Size, by Robotic Fusion, 2017-2032 (USD Million)
TABLE 314. European Union Prostate Fusion Biopsy Market Size, by Software Fusion, 2017-2032 (USD Million)
TABLE 315. European Union Prostate Fusion Biopsy Market Size, by Route, 2017-2032 (USD Million)
TABLE 316. European Union Prostate Fusion Biopsy Market Size, by Transperineal, 2017-2032 (USD Million)
TABLE 317. European Union Prostate Fusion Biopsy Market Size, by Transrectal, 2017-2032 (USD Million)
TABLE 318. European Union Prostate Fusion Biopsy Market Size, by Component, 2017-2032 (USD Million)
TABLE 319. European Union Prostate Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 320. European Union Prostate Fusion Biopsy Market Size, by Software, 2017-2032 (USD Million)
TABLE 321. European Union Prostate Fusion Biopsy Market Size, by Fusion Software, 2017-2032 (USD Million)
TABLE 322. European Union Prostate Fusion Biopsy Market Size, by Modality, 2017-2032 (USD Million)
TABLE 323. European Union Prostate Fusion Biopsy Market Size, by MRI-US Fusion, 2017-2032 (USD Million)
TABLE 324. European Union Prostate Fusion Biopsy Market Size, by PET-US Fusion, 2017-2032 (USD Million)
TABLE 325. European Union Prostate Fusion Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. European Union Prostate Fusion Biopsy Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 327. European Union Prostate Fusion Biopsy Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 328. European Union Prostate Fusion Biopsy Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 329. European Union Prostate Fusion Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 330. European Union Prostate Fusion Biopsy Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 331. European Union Prostate Fusion Biopsy Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 332. BRICS Prostate Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 333. BRICS Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 334. BRICS Prostate Fusion Biopsy Market Size, by Robotic Fusion, 2017-2032 (USD Million)
TABLE 335. BRICS Prostate Fusion Biopsy Market Size, by Software Fusion, 2017-2032 (USD Million)
TABLE 336. BRICS Prostate Fusion Biopsy Market Size, by Route, 2017-2032 (USD Million)
TABLE 337. BRICS Prostate Fusion Biopsy Market Size, by Transperineal, 2017-2032 (USD Million)
TABLE 338. BRICS Prostate Fusion Biopsy Market Size, by Transrectal, 2017-2032 (USD Million)
TABLE 339. BRICS Prostate Fusion Biopsy Market Size, by Component, 2017-2032 (USD Million)
TABLE 340. BRICS Prostate Fusion Biopsy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 341. BRICS Prostate Fusion Biopsy Market Size, by Software, 2017-2032 (USD Million)
TABLE 342. BRICS Prostate Fusion Biopsy Market Size, by Fusion Software, 2017-2032 (USD Million)
TABLE 343. BRICS Prostate Fusion Biopsy Market Size, by Modality, 2017-2032 (USD Million)
TABLE 344. BRICS Prostate Fusion Biopsy Market Size, by MRI-US Fusion, 2017-2032 (USD Million)
TABLE 345. BRICS Prostate Fusion Biopsy Market Size, by PET-US Fusion, 2017-2032 (USD Million)
TABLE 346. BRICS Prostate Fusion Biopsy Market Size, by End User, 2017-2032 (USD Million)
TABLE 347. BRICS Prostate Fusion Biopsy Market Size, by Ambulatory Surgery Centers, 2017-2032 (USD Million)
TABLE 348. BRICS Prostate Fusion Biopsy Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 349. BRICS Prostate Fusion Biopsy Market Size, by Specialty Clinics, 2017-2032 (USD Million)
TABLE 350. BRICS Prostate Fusion Biopsy Market Size, by Application, 2017-2032 (USD Million)
TABLE 351. BRICS Prostate Fusion Biopsy Market Size, by Diagnostic, 2017-2032 (USD Million)
TABLE 352. BRICS Prostate Fusion Biopsy Market Size, by Therapeutic, 2017-2032 (USD Million)
TABLE 353. G7 Prostate Fusion Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 354. G7 Prostate Fusion Biopsy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 355. G7 Prostate Fusion Biopsy Market Size, by Robotic Fusion, 2017-2032 (USD Million)
TABLE 356. G7 Prostate Fusion Biopsy Market Size, by Software Fusion, 2017-2032 (USD Million)
TABLE 357. G7 Prostate Fusion Biopsy Marke

Companies Mentioned

  • BioJet Systems GmbH
  • BioTrace Medical, LLC
  • BK Medical Holding Company, Inc.
  • Canon Medical Systems Corporation
  • CIVCO Medical Solutions, Inc.
  • Esaote S.p.A.
  • FUJIFILM Holdings Corporation
  • GE HealthCare Technologies Inc.
  • Hitachi, Ltd.
  • KOELIS SA
  • Koninklijke Philips N.V.
  • Medtronic plc
  • Siemens Healthineers AG

Related Topics

Related Reports

Ultrasound Fusion Biopsy Market - Global Forecast 2026-2032 - Product Image

Ultrasound Fusion Biopsy Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Fusion Biopsy - Global Strategic Business Report - Product Image

Fusion Biopsy - Global Strategic Business Report

  • Report
  • 277 Pages
  • Global
From
Fusion Biopsy - Market Insights, Competitive Landscape, and Market Forecast - 2034 - Product Image

Fusion Biopsy - Market Insights, Competitive Landscape, and Market Forecast - 2034

  • Report
  • 150 Pages
  • Global
From
Fusion Biopsy Market - Global Forecast 2026-2032 - Product Image

Fusion Biopsy Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Fusion Biopsy Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Fusion Biopsy Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.